Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
215.51
-1.26 (-0.58%)
Jan 8, 2026, 4:00 PM EST - Market closed

CRL Market Cap

CRL has a market cap or net worth of $10.61 billion as of January 9, 2026. Its market cap has increased by 11.65% in one year.

Market Cap
10.61B
Enterprise Value
13.03B
1-Year Change
11.65%
Ranking
Category
Stock Price
$215.51

Market Cap Chart

Since June 23, 2000, CRL's market cap has increased from $226.30M to $10.61B, an increase of 4,586.89%. That is a compound annual growth rate of 16.24%.

History

DateMarket Cap% Change
Jan 8, 202610.61B8.04%
Dec 31, 20259.82B4.00%
Dec 31, 20249.44B-22.16%
Dec 29, 202312.13B9.38%
Dec 30, 202211.09B-41.69%
Dec 31, 202119.01B52.98%
Dec 31, 202012.43B66.59%
Dec 31, 20197.46B37.05%
Dec 31, 20185.44B5.01%
Dec 29, 20175.18B43.75%
Dec 30, 20163.61B-3.79%
Dec 31, 20153.75B25.52%
Dec 31, 20142.99B17.00%
Dec 31, 20132.55B40.28%
Dec 31, 20121.82B34.64%
Dec 30, 20111.35B-34.13%
Dec 31, 20102.05B-7.60%
Dec 31, 20092.22B25.20%
Dec 31, 20081.77B-60.32%
Dec 31, 20074.47B54.46%
Dec 29, 20062.89B-5.57%
Dec 30, 20053.06B2.77%
Dec 31, 20042.98B89.75%
Dec 31, 20031.57B-9.52%
Dec 31, 20021.74B17.55%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company992.16B
Johnson & Johnson499.90B
AbbVie412.54B
UnitedHealth Group309.53B
AstraZeneca297.23B
Novartis AG273.49B
Merck & Co.269.55B
Novo Nordisk254.60B
Market Cap Rankings